Urinary oestrogen and plasma human placental lactogen as initial screening tests for a placental sulphatase deficiency.
As a result of routine screening of ante-natal patients by urinary total oestrogens and plasma human placental lactogen (HPL) from 35 weeks, a rare placental sulphatase deficiency was indicated which was later confirmed by in vitro studies of placental enzyme activities.
D000328:Adult; D004967:Estrogens / Q000652:urine*; D005260:Female; D006801:Humans; D010922:Placenta Diseases / Q000175:diagnosis* / Q000201:enzymology; D010928:Placental Lactogen / Q000097:blood*; D011247:Pregnancy; D013429:Sulfatases / Q000172:deficiency*
D004967:Estrogens; D010928:Placental Lactogen; D013429:Sulfatases